Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial
Humphrey et al., BMC Infectious Diseases, doi:10.1186/s12879-025-10584-4 (preprint 7/26/2023)
https://c19early.org/humphrey.html